Cocrystal Pharma, Inc. (COCP) Form 8-K — Aug 18, 2026
Cocrystal Pharma appointed Carol L. Brosgart to its Board of Directors effective August 12, 2026, as disclosed in an 8-K filed August 18, 2026. The filing states there are no arrangements or understandings behind her selection, no family relationships with the company's directors or executive officers, and no related-party transactions requiring disclosure under Item 404(a) of Regulation S-K.
Price after filing
1 day: +6.0%7 days: +4.6%30 days: +5.6%
Close on the filing date to close N calendar days later (from $1.08). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.